“…In view of the unique chemical and pharmacological properties (2,7,8,22,26) of these 2,2-dimethylaziridine derivatives as compared to their ring-C-unsubstituted aziridine analogs [i.e., the conventional "ethyleniminetype" alkylating agents, bis( 1 -aziridinyl)phosphinylurethan (IV), triethylenemelamine (V), tris( 1-aziridiny1)-phosphine oxide (VI), etc.] and in view of their apparently selective chemotherapeutic effects (26), it appeared worthwhile to investigate the reactions of these compounds in biological systems.…”